NO FEE UNLESS WE WIN
FREE CASE REVIEW

ATA: DOT, FMCSA must act to establish clearinghouse

On July 3, 2012, The Trucker published an article concerning the American Trucking Association’s (ATA) appeal to the Department of Transportation (DOT) and the Federal Motor Carrier Safety Administration (FMCSA) to create a national clearinghouse for drug and alcohol test results concerning commercial drivers.

Anticoagulant may cause irreversible bleeds

The Journal of Neurosurgery recently published a case report detailing the irreversible bleeding complications that may arise from use of dabigatran, the anticoagulant drug also known as Pradaxa.

Dallas hospital suspends kidney transplant program after transplant error

The Transplant Institute at Methodist Dallas Medical Center has voluntarily suspended its kidney and pancreas transplant program, according to a news report by WFAA-TV in Dallas/Ft. Worth. The decision to suspend the program comes a week after a transplant patient was mistakenly given a mismatched kidney.

Metal-on-Metal Hip Implant Concerns Reached 16,818 in a Decade

In preparation for an orthopaedic advisory panel meeting that will be held on June 27 and 28, 2012, the U.S. Food and Drug Administration (FDA) recently released a document detailing the number of metal-on-metal hip implant adverse event reports submitted to the agency in the past ten years.

Diabetes Drugs Carry Vision Risks

On June 11, 2012, the New York Times released an article concerning a recent study published by The Archives of Internal Medicine indicating that a certain type of drug used for treatment of Type 2 diabetes may lead to an increased risk for vision problems, including blindness.